NGM Biopharmaceuticals, Inc. (NGM) Financials
NGM Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 168.9 million | 20.2 million |
2023-09-30 | 192.2 million | 22.3 million |
2023-06-30 | 220.5 million | 28.4 million |
2023-03-31 | 258.8 million | 37.9 million |
NGM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -23.2 million | 6.3 million |
2023-09-30 | -27.5 million | 6.4 million |
2023-06-30 | -40.4 million | 7.5 million |
2023-03-31 | -42.5 million | 8.5 million |
NGM Net Income
No data available :(
NGM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 147.2 million | - | - |
2023-09-30 | 166.0 million | - | 1.4 million |
2023-06-30 | 193.5 million | - | 2.8 million |
2023-03-31 | 231.0 million | - | 4.1 million |
NGM Shares Outstanding
NGM Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 188000 | 21.4 million | 7.9 million | - |
2023-09-30 | 290000 | 22.9 million | 8.7 million | - |
2023-06-30 | 104000 | 32.4 million | 9.6 million | - |
2023-03-31 | 670000 | 40.9 million | 11.6 million | - |
NGM Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 165000 | 518000 |
2023-09-30 | 582000 | 500000 |
2023-06-30 | 1.4 million | 1.1 million |
2023-03-31 | 2.2 million | 1.1 million |
NGM
Price: $1.54
52 week price:
Earnings Per Share: -1.73 USD
P/E Ratio: -0.83
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 175000
Market Capitalization: 128.5 million